Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 25 , ISSUE 7 ( July, 2021 ) > List of Articles

Original Article

Gargling with 7.5% Sodium Bicarbonate Solution for SARS-CoV-2 Viremia Clearance: Our Institutional Clinical Experience

Mala Mahto

Keywords : 7.5% sodium bicarbonate, COVID-19, Gargling

Citation Information : Mahto M. Gargling with 7.5% Sodium Bicarbonate Solution for SARS-CoV-2 Viremia Clearance: Our Institutional Clinical Experience. Indian J Crit Care Med 2021; 25 (7):791-794.

DOI: 10.5005/jp-journals-10071-23901

License: CC BY-NC 4.0

Published Online: 07-07-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background: Gargling had been reported to have some roles in the prevention and treatment of respiratory tract infections. The purpose of this study was to assess the ability of regular gargling using 7.5% sodium bicarbonate to eliminate SARS-CoV-2 in the oropharynx and nasopharynx. Materials and methods: This pilot, open-labeled, nonrandomized, parallel single-center study. The effect of 30 seconds, three times per day gargling using 7.5% sodium bicarbonate solution—25 mL on SARS-CoV-2 viral clearance among coronavirus disease-2019 (COVID-19) patients in a dedicated COVID hospital at All India Institute of Medical Sciences, Patna, Bihar, India. We monitored the progress on by days 0, 1, 2, 3, 4, 5, 6, and 7 by observing variables like clinical category, P/F ratio, neutrophil/lymphocyte ratio (NLR) ratio, platelet count, ferritin, lactate dehydrogenase (LDH), CRP, procalcitonin, d-dimer, INR, APTT, and sequential organ function assessment (SOFA) score. We have also done repeat reverse transcription-polymerase chain reaction (RT-PCR) testing on day 5 and day 7. Results: A total of 10 patients (7 males and 3 females) were included in our study after confirmed COVID positivity. The age range was from 30 to 61 years. Based on clinical severity and P/F ratio, 7 patients were included in the milder group as their ratio was more than 200 and the rest 3 patients were included in the moderate group as P/F ratio was less than 200. Two respondents had comorbidities, which were non-Hodgkin\'s lymphoma and ovarian carcinoma. Viral clearance was achieved at day 7 in 3 of 10 patients. However, the analysis of using 7.5% sodium bicarbonate 25 mL gargle statistically showed nonsignificant p-value for all of our studied variables. However, the PCR results were negative on 24 hours apart, i.e., on day 5 and day 7. Conclusions: This is only a preliminary study which showed that gargling with 7.5% sodium bicarbonate may not be effective in achieving early SARS-CoV-2 viral clearance among mild COVID-19 patients. However, still larger studies are required to ascertain the benefit of gargling for different stages of COVID-19 patients with keeping in mind the important variables suggestive of viremia clearance.


PDF Share
  1. Mady LJ, Kubik MW, Baddour K, Snyderman CH, Rowan NR. Consideration of povidone-iodine as a public health intervention for COVID-19: utilization as “personal protective equipment’ for frontline providers exposed in high-risk head and neck and skull base oncology care.” Oral Oncol 2020;105:104724.2020. DOI: 10.1016/j.oraloncology.2020.104724.
  2. Pattanshetty S, Narayana A, Radhakrishnan R. Povidone-iodine gargle as a prophylactic intervention to interrupt the transmission of SARS-CoV-2. Oral Dis 2020;27(Suppl. 3):752–753. DOI: 10.1111/odi.13378.
  3. ECDC. 2020. Technical report: novel coronavirus (SARS-CoV-2) discharge criteria for confirmed COVID-19 Cases – when is it safe to discharge COVID-19 cases from the hospital or end home isolation? Available from: https://www.Ecdc.Europa.Eu/Sites/Default/Files/Documents/COVID-19-Discharge-Criteria.Pdf. 2020. p. 3.
  4. Sturman LS, Ricard CS, Holmes KV. Conformational change of the coronavirus peplomer glycoprotein at pH 8.0 and 37 degrees C correlates with virus aggregation and virus-induced cell fusion. J Virol. 1990;64(6):3042-3050. DOI:10.1128/JVI.64.6.3042-3050.1990
  5. Yang N, Shen HM. Targeting the endocytic pathway and autophagy process as a novel therapeutic strategy in COVID-19. Int J Biol Sci 2020;16(10):1724–1731. DOI: 10.7150/ijbs.45498.
  6. Bettermann E. Viral infections are pH sensitive; 2019. Available from: https://dreddymd.com/2019/02/06/viral-infections-are-ph-sensitive/ [Accessed on December 28, 2020].
  7. Uhm JS, Ahn JY, Hyun J, Sohn Y, Kim JH, Jeong SJ, et al. Patterns of viral clearance in the natural course of asymptomatic COVID-19: comparison with symptomatic non-severe COVID-19. Int J Infect Dis 2020;99:279–285. DOI: 10.1016/j.ijid.2020.07.070.
  8. Yang ZY, Huang Y, Ganesh L, Leung K, Kong WP, Schwartz O, et al. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J Virol 2004;78(11):5642–5650. DOI: 10.1128/JVI.78.11.5642-5650.2004.
  9. Kitamura T, Satomura K, Kawamura T, Yamada S, Takashima K, Suganuma N, et al. Can we prevent influenza-like illnesses by gargling? Intern Med 2007;46(18):1623–1624. DOI: 10.2169/internalmedicine.46.0104.
  10. O'Neil MJ, editor. The Merck Index – an encyclopedia of chemicals, drugs, and biologicals. Cambridge, UK: Royal Society of Chemistry; 2013. p. 1594.
  11. Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020;581(7809):465–469. DOI: 10.1038/s41586-020-2196-x.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.